Apogee Therapeutics, Inc. - APGE

Sector: Healthcare · Industry: Biological Products, (No Diagnostic Substances)

Website: No information yet · Social: No information yet

Company profile

Latest / Compare

Q1 2026 · Q4 2025

Value (USD)

Total reported value ($000)

$6.964B

QoQ value delta ($000)

+$1.751B (+33.58%)

Implied price effect (QoQ)

+10.89%

Total shares

83,198,822

QoQ shares delta

+14,132,456 (+20.46%)

Total shares held by funds (by quarter)

Interactive chart by TradingView.

Top 25 only Full list

Partial Q1 2026 data: 229 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.

Manager	Value ($000)	Shares	% of 13F
T. Rowe Price Investment Management, Inc.	867,034	10,300,984	0.6%
FMR LLC	779,606	9,262,291	0.04%
Venrock Adviser, LLC	714,882	8,493,321	26.68%
WELLINGTON MANAGEMENT GROUP LLP	368,302	4,375,703	0.07%
BlackRock, Inc.	343,889	4,085,651	0.01%
RTW INVESTMENTS, LP	234,169	2,782,097	2.33%
VANGUARD GROUP INC	215,708	2,857,824	0.0%
VANGUARD CAPITAL MANAGEMENT LLC	210,601	2,502,095	0.01%
JANUS HENDERSON GROUP PLC	198,808	2,360,596	0.09%
STATE STREET CORP	182,056	2,162,964	0.01%
DRIEHAUS CAPITAL MANAGEMENT LLC	161,673	1,920,800	1.19%
PERCEPTIVE ADVISORS LLC	129,654	1,540,384	2.54%
Paradigm Biocapital Advisors LP	113,481	1,348,243	2.32%
Affinity Asset Advisors, LLC	108,152	1,284,926	5.59%
GEODE CAPITAL MANAGEMENT, LLC	102,483	1,217,289	0.01%
UBS Group AG	96,318	1,144,328	0.01%
PRICE T ROWE ASSOCIATES INC /MD/	96,221	1,143,152	0.01%
Vestal Point Capital, LP	92,587	1,100,000	2.59%
FRONTIER CAPITAL MANAGEMENT CO LLC	89,597	1,064,483	0.92%
JPMORGAN CHASE & CO	87,416	1,110,470	0.01%
BANK OF AMERICA CORP /DE/	75,826	900,871	0.01%
ALLIANCEBERNSTEIN L.P.	74,747	990,297	0.02%
MERCER GLOBAL ADVISORS INC /ADV	69,981	831,428	0.1%
CITADEL ADVISORS LLC	54,929	652,602	0.01%
GOLDMAN SACHS GROUP INC	54,928	652,590	0.01%